MIDDLETON, Wis., July 29, 2025 /PRNewswire/ — Leo Cancer Care, a leader in upright radiotherapy solutions, today announces that its flagship product, Marie®, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Simple technology that harnesses ultraviolet light to zap airborne viruses has been shown to significantly lower the number of respiratory infections in aged care facilities, paving the way for smarter infection control.
A Northeastern University researcher has identified a way to target two of the deadliest cancer types, melanoma and triple negative breast cancer, with chemotherapy drugs but without the harms associated with chemotherapy.
An international research team has developed an easy online test capable of detecting toxoplasmosis infection without a blood sample, opening the door for a better understanding of how the common parasite affects human behavior.
Reliable and gentler control of cellular activity with light: Researchers at the Cluster of Excellence Multiscale Bioimaging (MBExC) and the Else Kröner Fresenius Center for Optogenetic Therapies (EKFZ OT) of the University Medical Center Göttingen (UMG) have developed a light-sensitive protein that can restore vision and hearing and regulate heart rhythm.
Johns Hopkins University researchers have grown a novel whole-brain organoid, complete with neural tissues and rudimentary blood vessels—an advance that could usher in a new era of research into neuropsychiatric disorders such as autism.
Dexcom (Nadsaq:DXCM) announced today that it released a new AI-powered photo meal logging feature for its Stelo platform.
Cardiosense announced today that it received FDA 510(k) clearance for its CardioTag wearable sensor device.
The test employs advanced RNA technology to identify biomarkers for colorectal cancer and advanced adenomas.
Designed for near-patient use, the test operates on an improved version of MeMed’s current platform.